FORT WORTH, Texas, June 29, 2021 /PRNewswire/ -- Galderma announced today the U.S. Food and Drug Administration (FDA) has approved Restylane ® Contour for cheek augmentation and correction of midface ...
“This approval reinforces our commitment to advancing our Injectable Aesthetics portfolio – the broadest on the market – to meet the diverse needs of patients. By expanding how innovations like ...
At ASDS 2025, Galderma unveiled pivotal new data from its range of pioneering Restylane ® hyaluronic acid (HA) injectables, highlighting its versatility in improving the chin profile with Restylane ...
Galderma, the pure-play dermatology category leader, today announced that the United States (US) Food and Drug Administration (FDA) has approved Restylane Lyft with Lidocaine for augmentation of the ...
ZUG, Switzerland - Galderma (SIX:GALD) announced Wednesday that the U.S. Food and Drug Administration has approved Restylane Lyft with Lidocaine for chin augmentation in patients over 21 with ...
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Restylane Lyft with Lidocaine for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback